GO:0016255 attachment of GPI anchor to protein: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016255 attachment of GPI anchor to protein describes a transamidation reaction that cleaves a newly synthesized polypeptide and transfers a preassembled glycosylphosphatidylinositol (GPI) anchor to the newly exposed carboxy-terminal amino acid.
• The reaction occurs in the endoplasmic reticulum and is catalyzed by the GPI transamidase complex, which recognizes a C-terminal GPI attachment signal sequence in the substrate protein.
• GPI-anchored proteins are ubiquitous in eukaryotes and are involved in cell signaling, adhesion, immune recognition, and membrane trafficking.
• Defects in GPI anchor attachment cause paroxysmal nocturnal hemoglobinuria (PNH) and other inherited GPI deficiency disorders.
• Key genes include PIGK, PIGT, PIGU, PIGS, GPAA1, and PIGV, which encode components of the transamidase and anchor biosynthesis machinery.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of GPI attachment in human cells.
Description
GO:0016255 attachment of GPI anchor to protein is a biological process in which a glycosylphosphatidylinositol (GPI) anchor is covalently attached to the carboxy terminus of a protein via a transamidation reaction. This post-translational modification occurs in the endoplasmic reticulum and is essential for the membrane localization and function of many cell-surface proteins. The reaction is catalyzed by the GPI transamidase complex, which cleaves the C-terminal GPI signal sequence of the substrate and simultaneously transfers the preassembled GPI anchor to the newly formed C-terminal amino acid. GPI-anchored proteins are found in all eukaryotes and participate in diverse biological processes, including signal transduction, cell adhesion, immune recognition, and development. Because GPI anchor attachment is required for the proper surface expression of many proteins, its dysfunction is linked to human diseases such as paroxysmal nocturnal hemoglobinuria (PNH) and inherited GPI deficiency syndromes. Understanding the molecular mechanism, regulation, and disease relevance of GO:0016255 is therefore important for both basic cell biology and translational research.
attachment of GPI anchor to protein At A Glance
| GO ID | GO:0016255 |
|---|---|
| GO term | attachment of GPI anchor to protein |
| Ontology | biological_process |
| Synonym | none |
| Major function | Transamidation reaction that cleaves a protein and attaches a GPI anchor to its new C-terminus |
| Cellular location | Endoplasmic reticulum membrane |
| Key enzyme complex | GPI transamidase (PIGK, PIGT, PIGU, PIGS, GPAA1) |
| Substrate feature | C-terminal GPI attachment signal sequence |
| Disease relevance | Paroxysmal nocturnal hemoglobinuria and inherited GPI deficiencies |
What Is GO:0016255?
In simple terms, GO:0016255 attachment of GPI anchor to protein is the step in which a GPI anchor is stitched onto the end of a protein. More precisely, it is a transamidation reaction that cleaves the polypeptide chain and simultaneously transfers the GPI anchor to the newly formed carboxy-terminal amino acid of the anchored protein. The cleaved C-terminal portion contains the C-terminal GPI signal sequence of the newly synthesized polypeptide chain.
Why Is attachment of GPI anchor to protein Important in Cell Biology?
GO:0016255 attachment of GPI anchor to protein is essential because it determines whether a large class of proteins can be displayed on the cell surface as GPI-anchored proteins. These proteins function in cell signaling, adhesion, immune recognition, and host-pathogen interactions, and their misregulation is associated with human disorders such as paroxysmal nocturnal hemoglobinuria and inherited GPI deficiency syndromes. Studying this process provides insight into fundamental membrane biology and offers potential therapeutic targets.
• Required for cell-surface expression of many signaling and adhesion proteins.
• Defects cause paroxysmal nocturnal hemoglobinuria (PNH) due to loss of GPI-anchored complement regulators.
• Mutations in GPI biosynthesis and transamidase genes cause inherited GPI deficiency disorders.
• GPI-anchored proteins are involved in immune recognition and pathogen entry.
• The process is conserved across eukaryotes, making model organisms useful for study.
• GPI anchor attachment can influence protein sorting and membrane microdomain localization.
• Aberrant GPI-anchored protein expression is observed in some cancers.
• The reaction is a potential target for antiparasitic and anticancer therapies.
• Understanding the mechanism aids in engineering GPI-anchored proteins for biotechnology.
• Research on GO:0016255 informs diagnosis of GPI anchor disorders.
What Happens During attachment of GPI anchor to protein?
Substrate recognition and ER targeting
In simple terms: The protein to be anchored is made in the ER and its tail is recognized by the anchoring machinery.
Newly synthesized proteins destined for GPI anchoring contain a C-terminal GPI attachment signal sequence that is recognized by the GPI transamidase complex in the endoplasmic reticulum. This signal sequence is both necessary and sufficient for the attachment reaction.
GPI transamidase complex assembly
In simple terms: A group of proteins forms a machine that performs the anchor attachment.
The GPI transamidase complex consists of five subunits: PIGK, PIGT, PIGU, PIGS, and GPAA1. PIGK contains the catalytic cysteine residue, while the other subunits are required for substrate recognition, complex stability, and transfer of the GPI anchor.
Transamidation and anchor transfer
In simple terms: The machine cuts the protein and attaches the GPI anchor to the new end.
The transamidation reaction cleaves the polypeptide chain at the omega site and simultaneously transfers the preassembled GPI anchor to the newly formed C-terminal amino acid. This results in the protein being covalently linked to the GPI anchor via an amide bond.
Quality control and ER exit
In simple terms: After attachment, the anchored protein is checked and sent to the cell surface.
Following GPI attachment, the protein undergoes quality control in the ER and is then transported to the Golgi and ultimately to the plasma membrane. Proper GPI anchor attachment is required for efficient ER exit and surface expression.
Remodeling of the GPI anchor
In simple terms: The anchor's lipid tails can be modified to fit the membrane.
After attachment, the GPI anchor can undergo lipid remodeling, including changes in fatty acid composition, which can affect protein sorting and membrane microdomain association.
Key Genes Involved in GO:0016255 attachment of GPI anchor to protein
The following genes encode proteins directly involved in GPI anchor biosynthesis, attachment, and remodeling, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PIGK | Catalytic subunit of GPI transamidase | Essential for GPI attachment; mutations cause GPI deficiency |
| PIGT | Component of GPI transamidase complex | Required for complex stability and substrate recognition |
| PIGU | Component of GPI transamidase complex | Involved in GPI anchor transfer |
| PIGS | Component of GPI transamidase complex | Required for GPI transamidase function |
| GPAA1 | Component of GPI transamidase complex | Required for GPI attachment; mutations linked to disease |
| PIGV | GPI mannosyltransferase in biosynthesis | Mutations cause inherited GPI deficiency |
| PIGA | Catalyzes first step of GPI biosynthesis | Somatic mutations cause PNH |
| PIGL | GPI biosynthesis enzyme | Defects cause GPI deficiency |
| PIGM | GPI biosynthesis enzyme | Defects cause GPI deficiency |
| PIGN | GPI biosynthesis enzyme | Defects cause GPI deficiency |
| PIGO | GPI biosynthesis enzyme | Defects cause GPI deficiency |
| PIGP | GPI biosynthesis enzyme | Defects cause GPI deficiency |
| PIGQ | GPI biosynthesis enzyme | Defects cause GPI deficiency |
| PIGW | GPI biosynthesis enzyme | Defects cause GPI deficiency |
| PIGY | GPI biosynthesis enzyme | Defects cause GPI deficiency |
| PGAP1 | GPI anchor remodeling | Involved in GPI anchor maturation |
| PGAP2 | GPI anchor remodeling | Involved in GPI anchor maturation |
| PGAP3 | GPI anchor remodeling | Involved in GPI anchor maturation |
How Is attachment of GPI anchor to protein Regulated?
The attachment of GPI anchor to protein is regulated at multiple levels, including transcriptional control of GPI biosynthesis and transamidase genes, availability of GPI anchor precursors, and ER quality control. The process is also influenced by the lipid composition of the ER membrane and by the activity of remodeling enzymes such as PGAP1, PGAP2, and PGAP3. Additionally, mutations in genes encoding the transamidase complex can lead to disease, indicating that tight regulation is essential.
attachment of GPI anchor to protein and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PIGA | Paroxysmal nocturnal hemoglobinuria | PIGA knockout in hematopoietic stem cells |
| PIGT | Inherited GPI deficiency | PIGT knockout or point mutation in cell lines |
| GPAA1 | Inherited GPI deficiency | GPAA1 knockout in HEK293 cells |
| PIGV | Inherited GPI deficiency | PIGV point mutation knock-in in patient-derived cells |
| PIGK | GPI transamidase deficiency | PIGK knockout in cancer cell lines |
Paroxysmal nocturnal hemoglobinuria (PNH)
Paroxysmal nocturnal hemoglobinuria is an acquired disorder caused by somatic mutations in PIGA, leading to loss of GPI-anchored proteins, including complement regulators CD55 and CD59, on blood cells. This results in complement-mediated hemolysis and thrombosis.
Inherited GPI deficiency disorders
Mutations in genes involved in GPI biosynthesis and attachment, such as PIGA, PIGV, PIGT, and GPAA1, cause a spectrum of inherited disorders characterized by developmental delay, seizures, and dysmorphic features.
Cancer
Altered expression of GPI-anchored proteins has been observed in various cancers, where they can promote cell proliferation, invasion, and immune evasion. Targeting GPI anchor attachment may therefore have therapeutic potential.
From attachment of GPI anchor to protein-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PIGK abolish GPI anchor attachment? | PIGK knockout cell line |
| Does a specific point mutation in PIGT affect transamidase activity? | PIGT point mutation knock-in |
| Can wild-type GPAA1 rescue GPI attachment in mutant cells? | GPAA1 knock-in or overexpression |
| Where does GPI transamidase localize in the ER? | Tagged knock-in of PIGK with fluorescent protein |
| What is the effect of GPI anchor remodeling on protein sorting? | PGAP1 knockout or overexpression |
| Can GPI-anchored proteins be detected on the cell surface? | Overexpression of tagged GPI-anchored protein |
How to Study the attachment of GPI anchor to protein Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Cell-surface GPI-anchored protein levels | Diagnosis of PNH and screening of mutants |
| Western blot | Protein size and expression of GPI-anchored proteins | Validation of knockout or knock-in |
| Mass spectrometry | GPI anchor lipid and glycan structure | Structural analysis of GPI anchors |
| CRISPR knockout screen | Genes required for GPI attachment | Discovery of novel GPI pathway components |
| Fluorescence microscopy | Subcellular localization of GPI-anchored proteins | ER and Golgi trafficking studies |
| Metabolic labeling | Incorporation of GPI precursors | Biosynthesis and attachment assays |
| RNA-seq | Transcriptional changes in GPI pathway genes | Expression profiling in disease models |
| Proteomics | Global GPI-anchored protein repertoire | Identification of novel GPI-anchored proteins |
Flow cytometry for GPI-anchored proteins
Flow cytometry using fluorescently labeled antibodies or GPI-specific probes such as aerolysin can quantify cell-surface GPI-anchored proteins and assess attachment efficiency.
Western blotting and metabolic labeling
Western blotting with antibodies against GPI-anchored proteins or metabolic labeling with radioactive GPI precursors can detect changes in GPI anchor attachment.
Mass spectrometry for GPI anchor structure
Mass spectrometry can determine the lipid composition and structure of GPI anchors attached to proteins, providing detailed biochemical information.
CRISPR screening for GPI attachment genes
Genome-wide CRISPR knockout screens coupled with GPI-anchored protein surface staining can identify genes required for GPI anchor attachment.
How CRISPR Can Be Used to Study GO:0016255 attachment of GPI anchor to protein
Knockout
CRISPR knockout of genes such as PIGK, PIGT, PIGU, PIGS, or GPAA1 abolishes GPI transamidase activity, leading to loss of GPI-anchored proteins from the cell surface. These models are useful for studying the consequences of GPI anchor deficiency and for validating gene function.
Point Mutation
CRISPR point mutation knock-in can introduce disease-associated missense mutations in GPI pathway genes, such as PIGT or PIGV, to model inherited GPI deficiency and assess residual enzyme activity.
Knock-in
Knock-in of epitope tags or fluorescent proteins into endogenous GPI pathway genes allows visualization and biochemical analysis of the transamidase complex and its substrates.
Overexpression
Overexpression of wild-type or mutant GPI pathway genes can rescue or dominate negative phenotypes, helping to establish causality and structure-function relationships.
How EDITGENE Supports attachment of GPI anchor to protein Research
Researchers studying attachment of GPI anchor to protein-related genes often need to determine whether a candidate gene is causally involved in the process, which requires precise genome editing and functional validation. EDITGENE provides a comprehensive suite of CRISPR services to support such investigations.
Contact EDITGENE today to design your custom CRISPR model for attachment of GPI anchor to protein research.
Frequently Asked Questions About attachment of GPI anchor to protein
What is GO:0016255 attachment of GPI anchor to protein?
GO:0016255 is a biological process describing the transamidation reaction that cleaves a protein and attaches a GPI anchor to its new C-terminus.
What genes are involved in attachment of GPI anchor to protein?
Key genes include PIGK, PIGT, PIGU, PIGS, and GPAA1, which encode the GPI transamidase complex, as well as biosynthesis genes like PIGA and PIGV.
Where does GPI anchor attachment occur in the cell?
It occurs in the endoplasmic reticulum membrane.
What is the function of GPI-anchored proteins?
They function in cell signaling, adhesion, immune recognition, and membrane trafficking.
What diseases are associated with defects in GPI anchor attachment?
Paroxysmal nocturnal hemoglobinuria and inherited GPI deficiency disorders are linked to defects in this process.
How can I study GPI anchor attachment in the lab?
Flow cytometry, western blotting, mass spectrometry, and CRISPR screens are commonly used methods.
What is the role of PIGK in GPI anchor attachment?
PIGK is the catalytic subunit of the GPI transamidase complex that performs the transamidation reaction.
Can CRISPR be used to model GPI anchor disorders?
Yes, CRISPR knockout and point mutation models can recapitulate GPI anchor deficiencies in cell lines.
What is the GPI attachment signal sequence?
It is a C-terminal sequence in the substrate protein that directs GPI anchor attachment.
How does GPI anchor attachment affect protein localization?
It anchors proteins to the outer leaflet of the plasma membrane and influences their sorting into lipid microdomains.
Conclusion
GO:0016255 attachment of GPI anchor to protein is a fundamental biological process that enables the cell-surface expression of a diverse array of proteins. Its mechanism involves a conserved transamidase complex and a transamidation reaction that cleaves and anchors proteins in the endoplasmic reticulum. Dysregulation of this process leads to human diseases such as paroxysmal nocturnal hemoglobinuria and inherited GPI deficiencies. Continued research using CRISPR models and advanced biochemical methods will further illuminate the regulation and therapeutic potential of GPI anchor attachment.
References
- 1. Kinoshita T. 2020. Biosynthesis and biology of mammalian GPI-anchored proteins.. Open Biol 10(3):190290 PMID: 32156170
- 2. Yuan Y et al.. 2024. Protein lipidation in health and disease: molecular basis, physiological function and pathological implication.. Signal Transduct Target Ther 9(1):60 PMID: 38485938
- 3. Varki A et al.. 2009. Glycosylphosphatidylinositol Anchors.. PMID: 20301281
- 4. Ikezawa H. 2002. Glycosylphosphatidylinositol (GPI)-anchored proteins.. Biol Pharm Bull 25(4):409-17 PMID: 11995915
- 7. Hernández-Campo PM et al.. 2008. [Paroxysmal nocturnal hemoglobinuria].. Med Clin (Barc) 131(16):617-30 PMID: 19080854
- 8. Aguilera-Romero A et al.. 2021. Determination of the lipid composition of the GPI anchor.. PLoS One 16(8):e0256184 PMID: 34388214
